Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Japan To Ban 5,000 Workers From Smoking On The Job (Japan)

This article was originally published in PharmAsia News

Executive Summary

As of April, ahead of Pfizer Japan's planned launch of Chantix (varenicline tartrate), its 5,000 employees are to be barred from smoking while on the job. The company already bans smoking at its Shinjuku headquarters, but it plans to ban the activity at sales sites and other locations, and in the company cars used by the 2,400 sales representatives. Pfizer Japan's smoking policy states it is inappropriate for employees of a health care company to smoke. (Click here for more - may require a subscription

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066754

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel